In a strategic move to address the growing financial and professional challenges facing the global scientific community, the Endocrine Society has unveiled a comprehensive suite of initiatives designed to support endocrine researchers at every stage of their careers. As the premier global organization representing professionals in the field of endocrinology, the Society’s latest efforts are centered on a three-pronged strategy: enhancing presentation opportunities, expanding scholarly publishing avenues, and fortifying mentorship programs. These initiatives come at a critical juncture when the scientific community is grappling with increased funding volatility and the need for more robust pathways for early-career investigators.
The centerpiece of this expansion is a significant enhancement of the Society’s financial support for its flagship annual meeting, ENDO 2026, which is scheduled to take place in Chicago, Illinois, from June 13 to June 16, 2026. This move, approved unanimously by the Board of Directors in early 2024, underscores the Society’s commitment to ensuring that economic barriers do not prevent groundbreaking research from reaching the global stage.
A Multi-Year Strategy for Research Presentation
The Endocrine Society’s commitment to scientific dissemination is most visible through its ENDO annual meetings, which serve as the primary conduit for the exchange of endocrine research. Recognizing that the cost of international and domestic travel remains a significant hurdle for many basic and clinical researchers, the Society has implemented a one-year expansion of its travel grant programs specifically for the 2026 cycle.
This expansion is not merely a budgetary increase but a targeted effort to diversify the voices present at the conference. By providing additional financial resources, the Society aims to attract a broader demographic of researchers, particularly those from underfunded institutions or developing regions. The ENDOExpo, a cornerstone of the annual meeting, typically hosts more than 2,500 abstracts. These posters and presentations represent the cutting edge of hormone research, covering topics from molecular biology to clinical trials.
To further amplify the reach of this research, the Society has integrated digital media strategies into its presentation prong. Selected researchers who submit abstracts are given the opportunity to participate in video interviews, which are then disseminated across the Society’s social media channels. In previous years, these videos have garnered thousands of views, providing researchers with a level of visibility that extends far beyond the physical confines of the conference hall. This digital engagement is particularly beneficial for early-career scientists looking to establish their professional reputation in a crowded field.
Strengthening the Scholarly Publishing Ecosystem
The second prong of the Society’s strategy focuses on the permanence and accessibility of scientific findings through its publishing house. A key benefit for researchers submitting abstracts to ENDO is the opportunity for their work to be published in a special supplement of the Journal of the Endocrine Society (JES). This open-access journal ensures that research is available to the public and the scientific community without the barriers of a paywall.
Every abstract published in the JES supplement is assigned a Digital Object Identifier (DOI). This unique alphanumeric string is essential in the modern research landscape, as it provides a permanent link to the research, making it easily citable and trackable through various impact metrics. In an era where "publish or perish" remains a dominant theme in academia, the provision of a DOI for conference abstracts allows researchers to demonstrate the immediate impact of their work to tenure committees and funding agencies.
Beyond the JES, the Society maintains a suite of top-ranked journals that have been at the forefront of endocrine science since 1917. These include Endocrinology, The Journal of Clinical Endocrinology & Metabolism (JCEM), and Endocrine Reviews. The Society offers its members reduced production costs for accepted manuscripts, a significant financial incentive given the rising costs of article processing charges (APCs) in the open-access era. The peer-review process at these journals is managed by thought leaders in the field, ensuring that research integrity and rigorous standards are maintained.
Mentorship and the Professional Pipeline
The third prong of the Society’s initiative is Mentorship, which aims to address the "leaky pipeline" in scientific research—the phenomenon where promising students and early-career researchers exit the field due to a lack of support or career clarity.
Two primary programs define this effort: the Research Experiences for Graduate and Medical Students (REGMS) and the Future Leaders Advancing Research in Endocrinology (FLARE) program.
REGMS is specifically designed to provide graduate and medical students with hands-on experience in collaborative laboratory environments. The program emphasizes the development of professional networks and technical skills through year-round activities. By pairing students with expert mentors, the Society ensures that the next generation of endocrine scientists is equipped with both the scientific knowledge and the professional acumen required to succeed.
The FLARE program caters to a slightly more advanced cohort, including graduate students, postdoctoral fellows, clinical fellows, and junior faculty. The focus of FLARE is the transition to independent research careers. Participants receive training in leadership, lab management, and grant writing—skills that are rarely taught in traditional scientific curricula but are essential for career longevity. The upcoming FLARE workshop, scheduled for March 26–28, 2024, will bring together a diverse group of participants to engage in intensive career development sessions.
Specialized Knowledge Development and Future Summits
In addition to the three main prongs, the Endocrine Society continues to invest in specialized educational programming. At the annual ENDO meetings, these include "Year in Review" sessions, which provide a high-level overview of the most significant developments in specific sub-fields, and "Meet the Scientist" sessions, which allow for informal interaction between established leaders and emerging researchers.
Looking ahead, the Society has announced a Basic Science Summit on Nuclear Receptors, to be held in Chicago in the fall of 2024. Nuclear receptors are a class of proteins found within cells that are responsible for sensing steroid and thyroid hormones and certain other molecules. They are central to many physiological processes and are key targets for drug development. This focused summit will provide a deep dive into the latest breakthroughs in this specific area of endocrinology, offering a more intimate setting for basic scientists to collaborate and share data.
Chronology of Key Initiatives and Events
The Endocrine Society’s current roadmap reflects a long-term commitment to the research community. The following timeline outlines the key milestones in this strategic expansion:
- January 2024: The Board of Directors unanimously approves the expansion of travel grants for the ENDO 2026 cycle to mitigate the impact of the global funding climate.
- March 26–28, 2024: The FLARE program hosts its annual workshop, focusing on leadership development for junior faculty and fellows.
- Fall 2024: The Basic Science Summit on Nuclear Receptors takes place in Chicago, providing a specialized forum for molecular and cellular endocrine research.
- Early 2025: Applications open for the 2026 travel grant program, with a focus on increasing participation from underrepresented groups in science.
- June 13–16, 2026: ENDO 2026 convenes in Chicago, marking the culmination of the expanded support initiatives with over 2,500 planned abstract presentations.
Analysis: The Implications of Professional Society Intervention
The Endocrine Society’s decision to increase its financial and professional support comes at a time when the National Institutes of Health (NIH) and other global funding bodies are facing stagnant or uncertain budgets. For many researchers, particularly those in the "basic science" category—where research is conducted to understand fundamental biological processes rather than immediate clinical applications—funding is increasingly difficult to secure.
By stepping in to provide travel grants, low-cost publishing, and mentorship, the Society is effectively acting as a stabilizer for the endocrine workforce. This intervention has several long-term implications:
- Workforce Retention: Programs like FLARE and REGMS are essential for keeping talented individuals in the endocrine field, preventing a "brain drain" to other better-funded specialties or private industry.
- Scientific Integrity: By maintaining a rigorous, member-supported publishing ecosystem, the Society ensures that endocrine research is vetted by experts rather than predatory journals, which have become a growing concern in scientific publishing.
- Global Collaboration: The focus on Chicago as a hub for 2026, combined with expanded travel support, fosters international collaboration. Endocrinology is a field where many conditions—such as diabetes, obesity, and thyroid disorders—are global epidemics that require cross-border scientific solutions.
- Translation of Research: The "bench to bedside" philosophy mentioned by Society leaders is supported by these initiatives. By helping basic scientists present and publish their work, the Society facilitates the transition of laboratory discoveries into clinical applications that eventually improve hormone health and patient outcomes.
The Endocrine Society’s proactive stance reflects a broader trend among scientific professional organizations to take a more active role in the career sustainability of their members. As the funding landscape continues to evolve, the success of these programs will likely serve as a model for other scientific disciplines. Through the strategic pillars of Presenting, Publishing, and Mentorship, the Society is not only supporting individual researchers but is also investing in the future of hormone health and scientific discovery.